Delaram Safarpour is a Neurology physician affiliated with Oregon Health & Science University. OpenAlex indexes 64 publications with 737 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3303 SW Bond Ave Ste 8
Portland, OR 972394501
Telephone
503-494-7772Registry record last updated 21 Jul 2022.
Clinical trials
- Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
Sponsor: CND Life Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202525 payments$17,674openpaymentsdata.cms.gov ↗
- ACADIA Pharmaceuticals IncProgram year20251 payment
- ABBVIE INC.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
97.2%Aromatic Amino Acid Decarboxylation Inhibitor46.6%Carbidopa-Levodopa64%Carbidopa-Levodopa Er22%Rytary14%Part D≥132 patientsBenzodiazepine5.8%Clonazepam100%Part D≥22 patients+ 15 more classes in this area
Hormonal (systemic)
1%Mineralocorticoids1%Fludrocortisone Acetate100%Part D<11 patientsAnti-infectives
1%Influenza A M2 Protein Inhibitor1%Rimantadine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Combined accelerometry and writing analysis for quantifying tremor during focused ultrasound thalamotomy
Journal of neurosurgery
2026 - Consensus expert recommendations for management of dysphagia during hospital admission in Parkinson's disease
Journal of Parkinson s Disease
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”